Numbers first: cagrilintide · 6.67 mg/mL.
This is a planning question. I know what my options are; I do not know how to weigh them.
What I want is the minimum viable version, which I suspect is smaller than what I would design.
What is the minimum version of this that is still defensible?
At 6.67 mg/mL a 0.25 mg dose is 3.7 units on a U-100 barrel and a 1 mg dose is 15 units. Volume is dose divided by concentration and one unit is 0.01 mL, so the unit count is dose ÷ 6.67 × 100. That puts the smaller dose below five units, where a half-graduation misread is more than ten per cent of the dose — reconstitute to a lower concentration if small doses are the point.
Answer first: diluent volume sets concentration and therefore resolution on the syringe barrel, and resolution is free at reconstitution and impossible to recover afterwards.
Content matters. If the same 10 mg vial assays at 94 per cent content, you have 9.4 mg. In 2 mL that is 4.7 mg/mL, and a nominal 0.5 mg draw of 10 units actually delivers 0.47 mg — a six per cent shortfall that no amount of careful drawing will fix.
Write the concentration and the resulting units-per-dose on the vial label at reconstitution. The arithmetic that is obvious now will not be obvious at six in the morning three weeks from now.
Published content assay results across the independent testing services show nominal and measured content differing by one to ten per cent, which makes content the dominant term in dose error.
Choose the volume that puts your largest intended dose between 10 and 30 units. Everything else follows.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsStart from the dose you intend to draw and work backwards to the volume that puts it in a readable part of the barrel.
Worked example. A 10 mg vial reconstituted with 2 mL gives 5 mg/mL. A 0.5 mg dose is 0.5 ÷ 5 = 0.1 mL, which on a U-100 syringe is 10 units. Reconstitute the same vial with 1 mL and the concentration doubles to 10 mg/mL, the same dose becomes 0.05 mL, and you are now reading 5 units instead of 10 — the same dose at half the resolution.
The other direction: 10 mg in 3 mL is 3.33 mg/mL, and a 0.5 mg dose becomes 0.15 mL, or 15 units. More barrel, easier reading, and a larger fraction of the vial volume lost to dead space across the same number of draws.
Insulin syringe barrel graduations are typically 1 unit on a 0.3 mL barrel, 1 unit on a 0.5 mL barrel and 2 units on a 1 mL barrel, which is why the barrel size changes what is readable.
Write the concentration on the label at reconstitution, in units per dose.
The relevant arithmetic is concentration equals vial content divided by diluent volume, and content is not the same as label claim.
Dead-space loss scales with the number of draws, not with the concentration, so a lower concentration spread over more draws loses proportionally less of the total peptide.
Vial headspace is the hard constraint. A nominal 2 mL vial typically holds a little over 2 mL to the shoulder; adding 3 mL is not an option and attempting it wastes the lot.
Measure a volume you can actually measure. Round numbers, real syringes.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.